Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Emerging Roles of Exosomes in the Chemoresistance of Hepatocellular Carcinoma
Jie Zhang, Qianqian Song, Mengna Wu, et al.
Current Medicinal Chemistry (2020) Vol. 28, Iss. 1, pp. 93-109
Closed Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

Cross-talk between cancer stem cells and immune cells: potential therapeutic targets in the tumor immune microenvironment
Bo Wu, Xiang Shi, Meixi Jiang, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 100
New insights into the pharmacological, immunological, and CAR-T-cell approaches in the treatment of hepatocellular carcinoma
Michele Dal Bo, Elena De Mattia, Lorena Baboçi, et al.
Drug Resistance Updates (2020) Vol. 51, pp. 100702-100702
Open Access | Times Cited: 77
Glucose Metabolism and Oxidative Stress in Hepatocellular Carcinoma: Role and Possible Implications in Novel Therapeutic Strategies
Monica Mossenta, Davide Busato, Michele Dal Bo, et al.
Cancers (2020) Vol. 12, Iss. 6, pp. 1668-1668
Open Access | Times Cited: 68
Autophagy, an accomplice or antagonist of drug resistance in HCC?
Yafei Wu, Jigang Zhang, Qin Li
Cell Death and Disease (2021) Vol. 12, Iss. 3
Open Access | Times Cited: 49
<p>Adipose Mesenchymal Stem Cell-Derived Exosomal microRNA-1236 Reduces Resistance of Breast Cancer Cells to Cisplatin by Suppressing SLC9A1 and the Wnt/β-Catenin Signaling</p>
Zhongming Jia, Huamin Zhu, Hongguang Sun, et al.
Cancer Management and Research (2020) Vol. Volume 12, pp. 8733-8744
Open Access | Times Cited: 43
Autophagy-modulating biomembrane nanostructures: A robust anticancer weapon by modulating the inner and outer cancer environment
Xinyi Zhang, Mengya Zhang, Hengqing Cui, et al.
Journal of Controlled Release (2023) Vol. 366, pp. 85-103
Closed Access | Times Cited: 14
Epigenetic and Immune-Cell Infiltration Changes in the Tumor Microenvironment in Hepatocellular Carcinoma
Zeng‐Hong Wu, Yang Dongliang, Liang Wang, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 29
KIFC3 regulates progression of hepatocellular carcinoma via EMT and the AKT/mTOR pathway
Shimin Lu, Yinghui Liu, Shan Tian, et al.
Experimental Cell Research (2023) Vol. 426, Iss. 1, pp. 113564-113564
Closed Access | Times Cited: 8
Connecting the Dots: The Cerebral Lymphatic System as a Bridge Between the Central Nervous System and Peripheral System in Health and Disease
Zhao Hongxiang, Meiyan Sun, Yue Zhang, et al.
Aging and Disease (2023) Vol. 15, Iss. 1, pp. 115-115
Open Access | Times Cited: 8
ASF1B is a Promising Prognostic Biomarker and Correlates With Immunotherapy Efficacy in Hepatocellular Carcinoma
Shirong Zhang, Longwen Xu, Jinteng Feng, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 14
Novel Nanotechnology Approaches to Overcome Drug Resistance in the Treatment of Hepatocellular Carcinoma: Glypican 3 as a Useful Target for Innovative Therapies
Monica Mossenta, Davide Busato, Michele Dal Bo, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 17, pp. 10038-10038
Open Access | Times Cited: 11
A Comprehensive Pan-Cancer Analysis for Pituitary Tumor-Transforming Gene 1
Siming Gong, Changwu Wu, Yingjuan Duan, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 9
Cancer Stem Cells and Their Vesicles, Together with Other Stem and Non-Stem Cells, Govern Critical Cancer Processes: Perspectives for Medical Development
Jacopo Meldolesi
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 2, pp. 625-625
Open Access | Times Cited: 8
Development of a Toll-Like Receptor-Based Gene Signature That Can Predict Prognosis, Tumor Microenvironment, and Chemotherapy Response for Hepatocellular Carcinoma
Lixia Liu, Bin Liu, Jie Yu, et al.
Frontiers in Molecular Biosciences (2021) Vol. 8
Open Access | Times Cited: 10
A Novel Epithelial-Mesenchymal Transition Gene Signature Correlated With Prognosis, and Immune Infiltration in Hepatocellular Carcinoma
Weihao Kong, Zhongxiang Mao, Han Chen, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 6
Molecular features, biological behaviors and clinical implications of m 5 C RNA methylation modification regulators in gastrointestinal cancers
Mengyao Zhan, Huan Song, Dan Tian, et al.
Cancer Biology & Therapy (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 3
LncRNA00978 contributes to growth and metastasis of hepatocellular carcinoma cells via mediating microRNA-125b-5p/SOX12 pathway
Zhiqing Cheng, Limei Gong, Qinghe Cai
Bioengineered (2022) Vol. 13, Iss. 4, pp. 11228-11239
Open Access | Times Cited: 5
Identification of an Epithelial-Mesenchymal Transition-Related Long Non-coding RNA Prognostic Signature to Determine the Prognosis and Drug Treatment of Hepatocellular Carcinoma Patients
Shenglan Huang, Dan Li, Lingling Zhuang, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 5
MiR-520a-5p/PPP5C regulation pattern is identified as the key to gemcitabine resistance in pancreatic cancer
Ruibiao Fu, Qian Shao, Bin Yang, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 5
Comprehensive Analysis to Identify the Epithelial–Mesenchymal Transition-Related Immune Signatures as a Prognostic and Therapeutic Biomarkers in Hepatocellular Carcinoma
Guozhi Wu, Yuan Yang, Yu Zhu, et al.
Frontiers in Surgery (2021) Vol. 8
Open Access | Times Cited: 6
Identification of three metabolic subtypes in gastric cancer and the construction of a metabolic pathway-based risk model that predicts the overall survival of GC patients
Tongzuan Chen, Liqian zhao, Junbo Chen, et al.
Frontiers in Genetics (2023) Vol. 14
Open Access | Times Cited: 2
Significance of exosomes in hepatocellular carcinoma
GuoYun Wang, GaiXiang Luo, MeiJing Zhao, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 4
Identification of the Immune Subtype of Hepatocellular Carcinoma for the Prediction of Disease-Free Survival Time and Prevention of Recurrence by Integrated Analysis of Bulk- and Single-Cell RNA Sequencing Data
Jie Fu, Xiaohua Lei
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 3
Immune cell responses in pancreatic cancer and their clinical application
Xulin Zhou, Yongmin Yan, Min Xu
European Journal of Inflammation (2022) Vol. 20, pp. 205873922110443-205873922110443
Open Access | Times Cited: 3
A Platelet-Powered Drug Delivery System for Enhancing Chemotherapy Efficacy for Liver Cancer Using the Trojan Horse Strategy
Hao Huang, Xiaoping Wang, Ziqing Gao, et al.
Pharmaceutics (2024) Vol. 16, Iss. 7, pp. 905-905
Open Access
Page 1 - Next Page

Scroll to top